-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Chemours, Lowers Price Target to $15

Benzinga·08/13/2026 15:22:02
语音播报
JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $22 to $15.